Get started
RocketTickers

Akebia Therapeutics Announces Positive Top-Line Results from Glo

Long
Akebia Therapeutics, Inc. (NASDAQ:AKBA)  
RocketTickers  
NASDAQ:AKBA   Akebia Therapeutics, Inc.
Beyond Technical Analysis
3
0
beyondta
AKBA: Akebia Therapeutics
2020-05-05 06:59:00
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.